Screening of novel excipients for freeze-dried protein formulations

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Screening of novel excipients for freeze-dried protein formulations. / Holm, Tobias Palle; Meng-Lund, Helena; Rantanen, Jukka; Jorgensen, Lene; Grohganz, Holger.

In: European Journal of Pharmaceutics and Biopharmaceutics, Vol. 160, 2021, p. 55-64.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Holm, TP, Meng-Lund, H, Rantanen, J, Jorgensen, L & Grohganz, H 2021, 'Screening of novel excipients for freeze-dried protein formulations', European Journal of Pharmaceutics and Biopharmaceutics, vol. 160, pp. 55-64. https://doi.org/10.1016/j.ejpb.2021.01.008

APA

Holm, T. P., Meng-Lund, H., Rantanen, J., Jorgensen, L., & Grohganz, H. (2021). Screening of novel excipients for freeze-dried protein formulations. European Journal of Pharmaceutics and Biopharmaceutics, 160, 55-64. https://doi.org/10.1016/j.ejpb.2021.01.008

Vancouver

Holm TP, Meng-Lund H, Rantanen J, Jorgensen L, Grohganz H. Screening of novel excipients for freeze-dried protein formulations. European Journal of Pharmaceutics and Biopharmaceutics. 2021;160:55-64. https://doi.org/10.1016/j.ejpb.2021.01.008

Author

Holm, Tobias Palle ; Meng-Lund, Helena ; Rantanen, Jukka ; Jorgensen, Lene ; Grohganz, Holger. / Screening of novel excipients for freeze-dried protein formulations. In: European Journal of Pharmaceutics and Biopharmaceutics. 2021 ; Vol. 160. pp. 55-64.

Bibtex

@article{8251e09e417f4fa7a240bcf928571a0c,
title = "Screening of novel excipients for freeze-dried protein formulations",
abstract = "The typical excipients used as bulking agents and lyoprotectants for freeze-drying are usually limited to only a few selected substances, such as sucrose and mannitol. Considering the sheer diversity amongst proteins, it is doubtful that this limited choice should, in every case, provide the best possible option in order to achieve the most stable product. In this work, a screening of 12 proteins with 64 excipients was conducted in order to increase the knowledge space of potential excipients. Three critical quality attributes (CQAs) of the freeze-dried products, namely the solid state, the cake appearance and the protein integrity based on changes in tryptophan fluorescence were investigated by high throughput X-ray powder diffraction, image analysis and intrinsic fluorescence spectroscopy, respectively. It was found, that in some cases the excipient had a dominating influence on the CQAs, whilst in other cases the CQAs were primarily protein dependent, or that the CQAs were dependent on the combination of both. In the course of this investigation, a general view of potentially relevant excipients, and their interplay with various proteins, was obtained, thereby furthermore paving the way for the use of novel freeze-drying excipients.",
keywords = "Excipients, Formulation development, Freeze-drying, High throughput, Image analysis, Intrinsic fluorescence spectroscopy, Protein stability, Solid state analysis",
author = "Holm, {Tobias Palle} and Helena Meng-Lund and Jukka Rantanen and Lene Jorgensen and Holger Grohganz",
year = "2021",
doi = "10.1016/j.ejpb.2021.01.008",
language = "English",
volume = "160",
pages = "55--64",
journal = "European Journal of Pharmaceutics and Biopharmaceutics",
issn = "0939-6411",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Screening of novel excipients for freeze-dried protein formulations

AU - Holm, Tobias Palle

AU - Meng-Lund, Helena

AU - Rantanen, Jukka

AU - Jorgensen, Lene

AU - Grohganz, Holger

PY - 2021

Y1 - 2021

N2 - The typical excipients used as bulking agents and lyoprotectants for freeze-drying are usually limited to only a few selected substances, such as sucrose and mannitol. Considering the sheer diversity amongst proteins, it is doubtful that this limited choice should, in every case, provide the best possible option in order to achieve the most stable product. In this work, a screening of 12 proteins with 64 excipients was conducted in order to increase the knowledge space of potential excipients. Three critical quality attributes (CQAs) of the freeze-dried products, namely the solid state, the cake appearance and the protein integrity based on changes in tryptophan fluorescence were investigated by high throughput X-ray powder diffraction, image analysis and intrinsic fluorescence spectroscopy, respectively. It was found, that in some cases the excipient had a dominating influence on the CQAs, whilst in other cases the CQAs were primarily protein dependent, or that the CQAs were dependent on the combination of both. In the course of this investigation, a general view of potentially relevant excipients, and their interplay with various proteins, was obtained, thereby furthermore paving the way for the use of novel freeze-drying excipients.

AB - The typical excipients used as bulking agents and lyoprotectants for freeze-drying are usually limited to only a few selected substances, such as sucrose and mannitol. Considering the sheer diversity amongst proteins, it is doubtful that this limited choice should, in every case, provide the best possible option in order to achieve the most stable product. In this work, a screening of 12 proteins with 64 excipients was conducted in order to increase the knowledge space of potential excipients. Three critical quality attributes (CQAs) of the freeze-dried products, namely the solid state, the cake appearance and the protein integrity based on changes in tryptophan fluorescence were investigated by high throughput X-ray powder diffraction, image analysis and intrinsic fluorescence spectroscopy, respectively. It was found, that in some cases the excipient had a dominating influence on the CQAs, whilst in other cases the CQAs were primarily protein dependent, or that the CQAs were dependent on the combination of both. In the course of this investigation, a general view of potentially relevant excipients, and their interplay with various proteins, was obtained, thereby furthermore paving the way for the use of novel freeze-drying excipients.

KW - Excipients

KW - Formulation development

KW - Freeze-drying

KW - High throughput

KW - Image analysis

KW - Intrinsic fluorescence spectroscopy

KW - Protein stability

KW - Solid state analysis

U2 - 10.1016/j.ejpb.2021.01.008

DO - 10.1016/j.ejpb.2021.01.008

M3 - Journal article

C2 - 33508435

AN - SCOPUS:85100060660

VL - 160

SP - 55

EP - 64

JO - European Journal of Pharmaceutics and Biopharmaceutics

JF - European Journal of Pharmaceutics and Biopharmaceutics

SN - 0939-6411

ER -

ID: 259823225